Personal Information

I am a fully trained biomedical scientist with deepened expertise in pharmacology.

Currently, I am working as an Associate Director German Market Access. I use my skills as an interdisciplinary, project-oriented scientist for medical writing and project-managing tasks within the value dossier team at Xcenda GmbH in Hannover, Germany.

I received my doctor´s degree at the Medical School Hannover.  As part of my thesis studies at the Institute for Pharmacology, I gained deepened knowledge in the fields of drug target interactions and receptor pharmacogenetics, focusing on seven transmembrane domain receptors (7TMR).

More specifically, I analyzed β₂-adrenoceptor-mediated signal transduction. The β₂-adrenoceptor is pathophysiologically relevant e.g. in case of bronchial asthma. My studies add to the receptor-pharmacological concept of functional selectivity. Functional selective (or biased ) ligands may be exploited to achieve highly selective drug effects and, thus, improved drug safety with less adverse effects. Further, I collaborated with allergy geneticists. Here we linked genomic and pharmacological profiling of the β₂-adrenoceptor in 60 volunteers.  Such pharmacogenomical data may help to stratify treatment groups and create a basis for a more effective, personalized asthma therapy.

• Project lead and management related to German early benefit assessments process according to § 35a SGB V (AMNOG) • Consulting and medical writing in context of market access and early benefit assessment in Germany • Go-To-Person for digital topics and Volunteer-Time-Off-activities

I deepened my research of molecular-pharmacological properties of the β₂-adrenergic receptor.

I generated pharmacological profiles of enantiopure β₂-adrenergic drugs using a recombinant receptor system.

I purified and characterized a membrane transporter protein.

I researched binding partners to an enzyme using co-immunoprecipitation.